Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: Role of sigma and imidazoline I2 receptors

Psychopharmacology

Volumn 167, Issue 2, 2003, Pages 211-218

  Culver, Kirsten E ^a   Szechtman, Henry ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

I2 receptor; Imidazoline; Intermittent versus continuous administration; Locomotion; MAOI displaceable quinpirole binding site (MQB); Mouthing; Sensitization; Sigma receptor

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMPHETAMINE; APOMORPHINE; BROMOCRIPTINE; CLORGYLINE; COCAINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I2 RECEPTOR; MONOAMINE OXIDASE INHIBITOR; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; PARGYLINE; QUINPIROLE; RO 411049; SIGMA OPIATE RECEPTOR; SPIPERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTINUOUS INFUSION; DRUG SENSITIZATION; LOCOMOTION; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

EID: 0038693644     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1408-z     Document Type: Article

References (36)

1. 2 imidazoline preferring-receptors. Br J Pharmacol 114:837-845
2. Angrist B (1983) Psychosis induced by central nervous system stimulants and related drugs. In: Creese I (ed) Stimulants: neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 1-30
3. Canadian Council on Animal Care (1993) Guide to the care and use of experimental animals, vol 1, 2nd edn. CCAC, Ottawa, Ontario
4. Clement H, Grote C, Wesemann W (1990) In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas. J Neural Transm Suppl 32:85-88
5. Colzi A, d'Agostini F, Kettler R, Borroni E, DaPrada M (1990) Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study. J Neural Transm 32:79-84
6. Culver KE, Szechtman H (1997) Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur J Pharmacol 339:109-111
7. Culver KE, Rosenfeld JM, Szechtman H (2000) A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology 151:202-210
8. Culver KE, Rosenfeld JM, Szechtman H (2002) Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition. Neuropharmacology 43:385-393
9. Eilam D, Szechtman H (1989) Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161:151-157
10. 2 receptors. Psychopharmacology 106:447-454
11. Greenshaw AJ (1986) Osmotic mini-pumps: a convenient program for weight adjusted filling concentrations. Brain Res Bull 16:759-761
12. Heeringa MJ, d'Agostini F, DeBoer P, DaPrada M, Damsma G (1997) Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behaviour. J Neural Transm 104:593-603
13. Hirabayshi M, Okada S, Tadokoro S (1991) Comparison of sensitization to ambulation-increasing effects of cocaine and methamphetamine after repeated administration in mice. J Pharm Pharmacol 43:827-830
14. 2 agonist bromocriptine show environment-specific sensitization following repeated injections. Psychopharmacology 107:277-284
15. Hudson HL, Gough R, Tyacke R, Lione L, Lalies M, Lewis J, Husbands S, Knight P, Murray F, Hutson P, Hutt DJ (1999) Novel selective compounds for the investigation of imidazoline receptors. Ann NY Acad Sci 881:81-91
16. Itzhak Y, Kassim CO (1990) Clorgyline displaces high affinity for sigma binding sites in C57BL/6 mouse brain. Eur J Pharmacol 176:107-108
17. Itzhak Y, Stein I, Zhang S, Kassim CO, Cristante D (1991) Binding of σ-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of σ-receptor subtypes. J Pharmacol Exp Ther 257:141-148
18. 3H]quinpirole binding in rat striatal membranes. Eur J Pharmacol 246:171-178
19. 3H]quinpirole binding in brain by monoamine oxidase inhibitors: Evidence for a potential novel binding site. J Pharmacol Exp Ther 278:145-153
20. A-deficient mice. Life Sci 70:229-241
21. 2 receptors. Eur J Pharmacol 353:123-135
22. Mattingly B, Gotsick S (1989) Conditioning and experimental factors affecting the development of sensitization to apomorphine. Behav Neurosci 103:1311-1317
23. Menkel M, Terry P, Pontecorvo M, Katz J, Witkin J (1991) Selective σ ligands block stimulant effects of cocaine. Eur J Pharmacol 201:251-252
24. Nutt D, French N, Handley S, Hudson A, Husbands S, Jackson S, Jordan S, Lalies M, Lewis J, Lione L, Mallard N, Pratt J (1995) Functional studies of specific imidazoline-2 receptor ligands. Ann NY Acad Sci 763:125-129
25. 3H]-idazoxan binding sites in the rat brain. Br J Pharmacol 108:597-603
26. Robinson TE, Becker JB (1986) Enduring change in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198
27. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
28. Sastre-Coll A, Esteban S, Miralles A, Zanetti R, Garcia-Sevilla J (2001) The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine releasing agent in the rat striatum in vivo. Neurosci Lett 301:29-32
29. Segal DS, Schuckit MA (1983) Animal models of stimulant-induced psychosis. In: Creese I (ed) Stimulants: neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 131-167
30. Szechtman H, Dai H, Mustafa S, Einat H, Sullivan RM (1994a) Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole. Pharmacol Biochem Behav 48:921-928
31. Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D (1994b) Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy mechanism. Psychopharmacology 115:95-104
32. Szechtman H, Culver KE, Eilam D (1999) Role of dopamine systems in obsessive-compulsive disorder: implications from a novel psychostimulant-induced animal model. Pol J Pharmacol 51:55-61
33. 1 receptors in methamphetamine-induced behavioral sensitization in rats. Neurosci Lett 289:21-24
34. Ujike H, Kanzaki A, Okumura K, Akiyama K, Otsuki S (1992a) Sigma antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci 50:129-134
35. Ujike H, Okumura K, Zushi Y, Akiyama K, Otsuki S (1992b) Persistent supersensitivity of σ receptors develops during repeated methamphetamine treatment. Eur J Pharmacol 211:23-328
36. Ujike H, Kuroda S, Otsuki S (1996) σ receptor antagonists block the development of sensitization to cocaine. Eur J Pharmacol 296:123-128